Maximum Recommended Dose of Enalapril
The maximum recommended dose of enalapril is 40 mg per day, administered either as a single dose or in two divided doses.
Dosing by Indication
Hypertension
- Target dose range: 10-40 mg daily 1
- Maximum dose: 40 mg per day 1
- Administration: Single dose or two divided doses 1
- In patients where once-daily dosing shows diminished effect toward the end of the dosing interval, consider twice-daily administration or dose increase 1
Heart Failure
- Target dose: 10-20 mg twice daily (total daily dose 20-40 mg) 2, 1
- Maximum dose tested in clinical trials: 40 mg in divided doses 1
- The landmark trials (CONSENSUS, SOLVD) used target doses of 20 mg twice daily (40 mg total daily) 3
- Evidence-based target: 10 mg twice daily based on major mortality trials 3, 2
Asymptomatic Left Ventricular Dysfunction
- Target dose: 10 mg twice daily (20 mg total daily) 1
- Patients should be titrated to this targeted dose as tolerated 1
Important Dosing Considerations
Renal Impairment
For hypertension with renal dysfunction 1:
- Normal function (CrCl >80 mL/min): 5 mg initial dose
- Mild impairment (CrCl 30-80 mL/min): 5 mg initial dose
- Moderate to severe (CrCl ≤30 mL/min): 2.5 mg initial dose, maximum 40 mg daily
- Dialysis patients: 2.5 mg on dialysis days
Heart Failure with Renal Impairment or Hyponatremia
- Start at 2.5 mg daily if serum creatinine >1.6 mg/dL or serum sodium <130 mEq/L 1
- Titrate gradually: 2.5 mg daily → 2.5 mg twice daily → 5 mg twice daily and higher
- Maximum remains 40 mg daily 1
Titration Strategy
Start low and go slow is the guiding principle 3, 4, 3:
- Begin with 2.5 mg daily (or 2.5 mg twice daily for heart failure) 3, 4
- Double the dose at intervals of at least 2 weeks 4
- Monitor blood pressure, renal function (creatinine), and potassium after each dose increase 3, 5
- Aim for evidence-based target doses from clinical trials, or the maximum tolerated dose 4, 5
Clinical Trial Evidence
The major heart failure trials established the efficacy of specific doses 3:
- CONSENSUS: Target 20 mg twice daily (mean achieved 18.4 mg daily)
- V-HeFT II: Target 10 mg twice daily (mean achieved 15.0 mg daily)
- SOLVD: Target 10 mg twice daily (mean achieved 16.6 mg daily)
The 2020 ACC/AHA guidelines explicitly state that the target dose for enalapril in heart failure is 10 mg twice daily (20 mg total daily), with at least 50% of target dose (10 mg total daily) recommended as a performance measure 2.
Safety Monitoring
When approaching maximum doses, monitor closely for 3, 5:
- Hypotension: Asymptomatic hypotension does not require dose reduction
- Renal function: Creatinine increase up to 50% from baseline or to 265 μmol/L (3 mg/dL) is acceptable
- Hyperkalemia: Potassium >5.5 mmol/L warrants dose reduction; >6.0 mmol/L requires discontinuation
- Avoid concomitant NSAIDs, potassium supplements, and potassium-sparing diuretics 3, 5
Common Pitfall
Do not confuse the maximum FDA-approved dose (40 mg daily) with the evidence-based target dose for heart failure (20 mg daily in divided doses). While 40 mg was tested in clinical trials, the mortality benefit was established at 20 mg daily (10 mg twice daily) 3, 2, 1. Higher doses may reduce heart failure hospitalizations but have not shown additional mortality benefit 6.